Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clavubactin batches recalled over reduced efficacy
'This recall is because the efficacy of the product cannot be guaranteed after 12 months' - VMD.

Vets and wholesalers urged to examine their inventory immediately

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for batches of the antibiotic Clavubactin, manufactured by Le Vet Pharma.

In a news release, the VMD writes: ‘We wish to make wholesalers and veterinary surgeons aware that Le Vet Pharma has issued a recall for batches of Clavubactin 50/12.5mg (Vm 19994/4028), Clavubactin 250/62.5mg (Vm 19994/4026), Clavubactin 500/125mg (Vm 19994/4027), all distributed by Animalcare and Dechra.

‘During routine stability testing the above-mentioned products do not fulfil the mandatory testing requirements at 24 months. This recall is because the efficacy of the product cannot be guaranteed after 12 months.’

The recall affects the following batches:

Product names Batch numbers Expiry
Clavubactin 50/12.5 mg 19D82 04-2021
  18D11 04-2020
  18G32 07-2020
Clavubactin 250/62.5 mg 19D83 04-2022
  17F46 06-2020
  17H35 08-2020
  18D13 04-2021
Clavubactin 500/125 mg 19D88 04-2022
  17C80 03-2020
  17F47 06-2020
  17H38 08-2020
  18D17 04-2021
  18D18 04-2021
  18G34 04-2022


Veterinary surgeons and wholesalers are urged to examine their inventory without delay and quarantine products subject to this recall.

For more information, please contact the relevant distributor:

Animalcare: Sameer Hashmi: shashmi@animalcare.co.uk
Dechra: Tracey Smith: tracey.smith@dechra.com

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'